Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > Articles by: Janet Fricker

Posts by author

Janet Fricker

223 posts
Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.
Nobel Prize for medicine awarded for discovery of microRNAs, which play key role in cancer development
View Post
  • News

Nobel Prize for medicine awarded for discovery of microRNAs, which play key role in cancer development

  • Janet Fricker
  • 10 October 2024

The 2024 Nobel Prize in Physiology or Medicine, announced on Monday 7 October, has been awarded jointly to Victor Ambros and Gary Ruvkun for discovering microRNAs and their role in post-transcriptional gene regulation. The work by Ambros, now at the…

View Post
ESMO launches initiative to tackle burnout in oncology healthcare professionals
View Post
  • News

ESMO launches initiative to tackle burnout in oncology healthcare professionals

  • Janet Fricker
  • 27 September 2024

The European Society for Medical Oncology (ESMO) is calling on the oncology community to commit to improving the wellbeing of the cancer workforce. In a paper published in ESMO Open, 10 September, ESMO outlines 11 actions to manage psychosocial risks,…

View Post
Antibody-drug conjugate proves effective against active brain metastases
View Post
  • News

Antibody-drug conjugate proves effective against active brain metastases

  • Janet Fricker
  • 26 September 2024

The antibody drug conjugate trastuzumab deruxtecan (T-DXd) showed substantial intracranial activity in patients with HER2-positive breast cancer whose disease had metastasised to the brain. The DESTINY-Breast12 study, presented at the Congress of the European Society for Medical Oncology (ESMO), held…

View Post
Safely pausing or stopping treatment: could this be the future for solid tumours?
View Post
  • Articles
  • Practice Points

Safely pausing or stopping treatment: could this be the future for solid tumours?

  • Janet Fricker
  • 12 September 2024

The success of treatment cessation in chronic myeloid leukaemia (CML), outlined in an earlier Cancerworld feature, is opening the way for treatment breaks – or cessation with monitoring – to be considered in advanced solid tumours, including breast, kidney, colorectal,…

View Post
Early menopause raises own risk of breast cancer and family members’ risk of breast, colon and prostate cancers
View Post
  • News

Early menopause raises own risk of breast cancer and family members’ risk of breast, colon and prostate cancers

  • Janet Fricker
  • 12 September 2024

Women who experience primary ovarian insufficiency (menopause before the age of 40) are more than twice as likely to experience breast cancer as other women of similar ages. The study, published in the Journal of Clinical Endocrinology and Metabolism, 12…

View Post
Raised suicide risk highlights need to support patient’s spouse
View Post
  • News

Raised suicide risk highlights need to support patient’s spouse

  • Janet Fricker
  • 12 September 2024

The spouses of patients diagnosed with cancer were 28% more likely to attempt suicide and 47% more likely to succeed at their attempt than spouses of people not diagnosed. The Danish cohort study, published in Jama Oncology, August 15, found…

View Post
Aspirin prevents colorectal cancer best in those with least healthy lifestyles
View Post
  • News

Aspirin prevents colorectal cancer best in those with least healthy lifestyles

  • Janet Fricker
  • 29 August 2024

Regular aspirin may help lower risk of colorectal cancer most effectively in people who have greater lifestyle-related risk factors for the disease. The study, published in JAMA Oncology on 1 August, found that, to prevent one case of colorectal cancer…

View Post
Endometriosis: impact on ovarian cancer varies by subtype
View Post
  • News

Endometriosis: impact on ovarian cancer varies by subtype

  • Janet Fricker
  • 28 August 2024

Women with endometriosis have a fourfold higher risk of any type of ovarian cancer and those with severe endometriosis a 10 fold higher risk compared to women who do not have the condition. The study, which involved a cohort of…

View Post
Disadvantaged neighbourhoods may contribute to racial disparities in risk of aggressive prostate cancer
View Post
  • News

Disadvantaged neighbourhoods may contribute to racial disparities in risk of aggressive prostate cancer

  • Janet Fricker
  • 1 August 2024

Men with prostate cancer living in disadvantaged neighbourhoods show significantly higher activity of stress-related genes than those living in other neighbourhoods. The observational study, published in JAMA Network Open, 12 July, found that neighbourhood disadvantage was positively associated with the…

View Post
Exercise boosts anti-tumour immune cells in people with breast cancer
View Post
  • News

Exercise boosts anti-tumour immune cells in people with breast cancer

  • Janet Fricker
  • 29 July 2024

Just 30 minutes of exercise increases the proportion of tumour-killing immune cells in the blood of people with breast cancer. The Finnish study, published in Frontiers in Immunology, 24 June, found that the proportion of CD8+ T cells and natural…

View Post

Posts pagination

Previous 1 2 3 4 5 … 23 Next
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld issue #103 (May, 2025)
    • 11 May 2025
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
Article
  • Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That
    • 27 May 2025
  • A Promise Kept: How Samvel Danielyan Lifted Pediatric Cancer Survival from Zero to 70%
    • 25 May 2025
  • Together, She Changed Everything: Martine Piccart ’s Fight Against Breast Cancer
    • 20 May 2025
Social

Would you follow us ?

Contents
  • A Promise Kept: How Samvel Danielyan Lifted Pediatric Cancer Survival from Zero to 70%
    • 25 May 2025
  • Together, She Changed Everything: Martine Piccart ’s Fight Against Breast Cancer
    • 20 May 2025
  • Adrian Gottschalk: Making a Difference for His Fellow Human Beings
    • 10 May 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.